Abstract
Community-acquired pneumonia (CAP) is not a homogeneous entity. S. pneumoniae is the most prevalent pathogen associated with severe CAP and is responsible for two-thirds of CAP-related deaths. Today, there is a need for effective strategies to develop and establish the optimum dosage regimen of new antimicrobial options. Morbidity and mortality in cases with severe CAP are determined by a complex interaction between host factors, features of the microorganism and the therapy administered. The major challenge that CAP presents is the early recognition of subsets requiring Intensive Care Unit (ICU) admission. Despite recent advances in antibiotic therapy, severe CAP remains associated with unacceptable levels of mortality. The present manuscript summarizes the current key points that should be taken into account in the strategies for severe CAP management.
Keywords: Community-acquired pneumonia, CAP, sepsis, ICU management, outcome, homogeneous, antimicrobial, host factors, mortality, ANTIBIOTIC USAGE
Current Respiratory Medicine Reviews
Title: Current Key Points in Management for Severe Community-Acquired Pneumonia
Volume: 7 Issue: 4
Author(s): Ignacio Martin-Loeches, Thiago Lisboa and Jordi Rello
Affiliation:
Keywords: Community-acquired pneumonia, CAP, sepsis, ICU management, outcome, homogeneous, antimicrobial, host factors, mortality, ANTIBIOTIC USAGE
Abstract: Community-acquired pneumonia (CAP) is not a homogeneous entity. S. pneumoniae is the most prevalent pathogen associated with severe CAP and is responsible for two-thirds of CAP-related deaths. Today, there is a need for effective strategies to develop and establish the optimum dosage regimen of new antimicrobial options. Morbidity and mortality in cases with severe CAP are determined by a complex interaction between host factors, features of the microorganism and the therapy administered. The major challenge that CAP presents is the early recognition of subsets requiring Intensive Care Unit (ICU) admission. Despite recent advances in antibiotic therapy, severe CAP remains associated with unacceptable levels of mortality. The present manuscript summarizes the current key points that should be taken into account in the strategies for severe CAP management.
Export Options
About this article
Cite this article as:
Martin-Loeches Ignacio, Lisboa Thiago and Rello Jordi, Current Key Points in Management for Severe Community-Acquired Pneumonia, Current Respiratory Medicine Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339811798281214
DOI https://dx.doi.org/10.2174/157339811798281214 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Current Genomics Neuropeptide Systems and Schizophrenia
CNS & Neurological Disorders - Drug Targets Recent Applications of Doebner, Doebner-von Miller and Knoevenagel-Doebner Reactions in Organic Syntheses
Current Organic Synthesis Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
Current Cancer Therapy Reviews Introduction to the Special Issue “Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems
Recent Patents on CNS Drug Discovery (Discontinued) Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Polyphenols from Red Wine Modulate Immune Responsiveness: Biological and Clinical Significance
Current Pharmaceutical Design Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult
Current Neuropharmacology Structure-Function Relationships of Iodinated Contrast Media and Risk of Nephrotoxicity
Current Medicinal Chemistry Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Advances in the Synthesis of Calystegines and Related Products and their Biochemical Properties
Mini-Reviews in Medicinal Chemistry Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis
Recent Patents on Biomedical Engineering (Discontinued) Protective Effect of Dietary Potassium against Cardiovascular Damage in Salt-Sensitive Hypertension: Possible Role of its Antioxidant Action
Current Vascular Pharmacology Recent Advances in the Management of Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders
Current Medicinal Chemistry Targeted Inhibition of AKT in Pancreatic Cancer
Current Cancer Therapy Reviews Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease
Current Stem Cell Research & Therapy Glucocorticoid Measurements in Health and Disease - Metabolic Implications and the Potential of 24-h Urine Analyses
Mini-Reviews in Medicinal Chemistry